Healthcare operations

HUTCHMED announces significant progression-free survival improvement in SANOVO trial combining ORPATHYS® and TAGRISSO® for MET-overexpressing EGFR-mutated lung cancer patients in China.

• leftbrainmarketing Team
• 31. August 2026

HUTCHMED’s ATLED® (Fanregratinib) gains approval from China’s NMPA for intrahepatic cholangiocarcinoma treatment, marking a key regulatory milestone.

• leftbrainmarketing Team
• 28. August 2026

Rznomics has joined Lilly Gateway Labs in San Diego to accelerate development of RNA-based therapeutics, marking a strategic collaboration in biotech innovation.

• leftbrainmarketing Team
• 24. August 2026

ArcherFRS partners with Hillsborough County Fire Rescue and Tampa General Hospital to pilot the first EMS-led drone delivery of whole blood, enhancing emergency medical response.

• leftbrainmarketing Team
• 8. August 2026

LeMaitre will participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference, scheduled for this month, highlighting its latest developments.

• leftbrainmarketing Team
• 7. August 2026